Nuvaring Side Effects Lawsuit
NuvaRing, a composition of ethinyl estradiol and etonogestrel, is a contraceptive vaginal ring available on prescription. The flexible plastic contraceptive ring, manufactured by Merck & Co, Organon BioSciences, and Schering-Plough, releases a low dose of progestin and estrogen hormones over a period of three weeks. The FDA approved NuvaRing on October 3, 2001, and over 1.5 million women worldwide use the contraceptive ring. However, two studies link NuvaRing with serious device-related side effects. More than 15.1 percent of the users have discontinued the use of the device after experiencing sexual problems, foreign object sensation, and expulsion.
More than 730 personal injury and wrongful death Lawsuit have been filed against the manufacturer and marketer of NuvaRing for failing to warn consumers about the health risks associated with NuvaRing, including possible blood clot complications and related injuries, such as deep vein thrombosis, pulmonary embolism, heart attacks and strokes.
In March 2008, a lawsuit was filed against Merck for not disclosing health risks associated with the device usage. The lawsuit claims that the use of NuvaRing had caused death of the plaintiff's wife. While Merck continues to deny the allegations, trials for many Lawsuit are scheduled for 2012. Many Lawsuit find major problems with the advertising of NuvaRing, which downplays the threat of risks associated with the device.